Patient Characteristics prior to re-BRT | n =37 |
---|---|
Age (years) | Â |
   Median | 48 |
KPS | Â |
   < 70 | 10 (27%) |
   ≥ 70 | 27 (73%) |
ECOG | Â |
   0-1 | 12 (32%) |
   2 | 20 (54%) |
   3-4 | 5 (13%) |
Number of lesions | Â |
   1-3 | 15 (40%) |
   > 3 | 22 (59%) |
Primary status | Â |
   Controlled | 22 (59%) |
   Uncontrolled | 15 (40%) |
Extracranial disease | Â |
   Brain only | 10 (27%) |
   Bone | 6 (16%) |
   Visceral | 19 (51%) |
   Other | 2 (5%) |
RPA at re-BRT | Â |
   1 | 12 (32%) |
   2 | 10 (27%) |
   3 | 15 (40%) |
Chemotherapy at BM* | Â |
   Yes | 19 (51%) |
   No | 18 (49%) |
Trastuzumab at BM* | Â |
   Yes | 6 (16%) |
   No | 31 (84%) |